Inflammatory markers implicated in the severity and prognosis of COVID-19 include increased Neutrophil-to-Lymphocyte ratio (NLR), C-reactive protein (CRP), and decreased Lymphocyte-to-C-reactive protein ratio (Lym-to-CRP) [7–10]. The gene discussed is CRP; the disease is COVID-19.